BioSpace News Archive

Parexel, a leading global clinical research organization focused on development and delivery of innovative new therapies to advance patient health, announced the appointment of five former regulators to its Regulatory & Access Consulting team, further accelerating the advancement of new treatments for patients worldwide.

Abbott announced three-year data showing the positive impact of the Amplatzer Piccolo™ Occluder on treating babies with a potentially life-threatening hole in the heart known as a patent ductus arteriosus.

MilliporeSigma, the U.S. and Canada Life Science business of Merck KGaA, Darmstadt, Germany, a leading science and technology company, announced that the Life Science business strengthened its manufacturing capabilities for single-use assemblies, a key technology for the production of Covid-19 vaccines and other lifesaving therapies, by investing € 130 million in Molsheim, France.

Cassava Sciences, Inc. (Nasdaq: SAVA), a clinical-stage biotechnology company focused on Alzheimer’s disease, announced today that it has been invited to present a corporate overview at the H.C. Wainwright 24th Annual Global Investment Conference, being held in New York.